Table 2 HRs and 95% CIs of various comparisons between molecular subtypes of breast cancer stratified by recurrence types

Hattangadi[30]

TR

NM

NM

NM

4.80 (1.40, 15.80)^M

NM

NM

NM

NM

Zauls[31]

LF

NM

NM

NM

NM

0.75 (0.15, 3.85)^U

0.55 (0.12, 2.44)^U

0.64 (0.07, 5.88)^U

NM

Han[32]

LR

1.90 (0.90, 4.00)^U

1.90 (0.90, 3.80)^U

0.60 (0.10, 2.40)^U,DE

NM

0.87 (0.48, 1.58)^U

1.09 (0.61, 1.98)^U,DE

1.98 (1.11, 3.53)^M,DE

NM

Millar[33]

LR

2.48 (0.98, 6.29)^M

1.93 (0.38, 9.75)^M

3.94 (1.28, 12.11)^M

NM

NM

NM

NM

1.20 (0.57, 2.55)^U,DE

Millar[33]

DM

2.87 (1.33, 6.22)^M

1.83 (0.39, 8.64)^M

3.27 (1.14, 9.40)^M

NM

NM

NM

NM

2.57 (1.30, 5.06)^U

Millar[33]

LR + DM

2.71 (1.49, 4.90)^M,DE

1.88 (0.61, 5.76)^M,DE

3.89 (2.03, 7.44)^M,DE

NM

NM

NM

NM

1.83 (1.10, 3.02)^U,DE

Moran[34]

LR

NM

NM

NM

2.21 (0.63, 7.81)^M

NM

NM

1.22 (0.30, 4.93)^M

NM

Bantema[34]

LRR + DM

NM

NM

NM

3.03 (1.37, 6.67)^M

NM

NM

NM

NM

Wong[35]

LR

NM

NM

NM

3.30 (1.20, 9.60)^U

NM

NM

NM

NM

Wong[35]

DM

3.60 (1.10, 11.30)^U

6.00 (1.60, 22.60)^U

4.20 (1.10, 16.00)^U

NM

NM

NM

NM

NM

Wong[35]

LR + DM

2.16 (0.85, 5.50)^M

2.22 (1.08, 9.84)^M

3.48 (1.22, 9.93)^M

NM

NM

NM

NM

NM

Kim[36]

IBTR

1.55 (0.32, 7.51)^M

0.55 (0.05, 6.34)^M

1.17 (0.22, 6.26)^M

NM

NM

NM

NM

NM

Arvold[38]

LR

2.10 (0.95, 4.80)^M

5.20 (1.80, 15.00)^M

3.90 (1.70, 9.00)^M

NM

NM

NM

NM

NM

Truong[39]

LRR

NM

NM

NM

NM

1.29 (0.99, 1.69)^M

NM

NM

NM

Sharon[40]

LR

NM

NM

NM

NM

NM

NM

1.93 (1.02, 3.65)^M

NM

Roos[41]

LR

NM

NM

NM

NM

2.50 (0.42, 10.00)^U,DE

1.11 (0.24, 5.00)^U,DE

3.90 (0.80, 20.10)^U

4.00 (0.90, 18.10)^U

Yau[42]

IBTR

NM

NM

NM

NM

NM

NM

2.19 (0.76, 6.35)^U

NM

Yau[42]

DF

NM

NM

NM

NM

NM

NM

2.17 (0.99, 4.75)^U

NM

Yau[42]

IBTR + DF

NM

NM

NM

NM

NM

NM

1.57 (1.26, 1.97)^U,DE

NM

Smith[43]

SIBC

NM

NM

NM

NM

NM

1.49 (1.00, 2.22)^U

NM

NM

Silvestrini[44]

LR

NM

NM

NM

NM

1.12 (0.42, 2.97)^U,DE

NM

NM

1.75 (1.44, 2.11)^U,DE